세계의 편평태선 시장 보고서(2025년)

Lichen Planus Global Market Report 2025

US $ 4,490 ￦ 6,222,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,993,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,765,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

편평태선 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장 전망은 생물학적 치료제에 대한 수요 증가, 새로운 치료 옵션에 대한 지속적인 임상 연구, 원격 피부과 서비스의 확대, 맞춤형 의료에 대한 강조 강화, 신흥 지역에서의 의료 인프라 개발 등에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 표적 생물학적 제제의 발전, 피부과 진단에 인공 지능의 적용, 혁신적인 의약품 전달 시스템, 원격 의료 플랫폼의 채택, 피부 모니터링을 위한 웨어러블 기기, 3D 피부 이미징 기술의 사용 등이 있습니다.

자가 면역 질환의 유병률이 증가함에 따라 앞으로 몇 년 동안 편평태선 시장이 성장할 것으로 예상됩니다. 자가면역 질환은 면역 체계가 신체 자체의 건강한 조직을 공격하는 경우 발생합니다. 이 질환에는 류마티스 관절염, 루푸스, 제1형 당뇨병, 다발성 경화증, 건선 등이 포함됩니다. 자가면역 질환의 증가에는 유전적 소인이 영향을 미치며, 특정 유전자 변이가 면역 체계 기능에 영향을 미치거나 결합 조직의 이상이 관련될 수 있습니다. 자가면역 질환의 증가 추세는 면역 체계의 조절 장애라는 더 넓은 문제를 반영하며, 편평태선 사례 증가와도 연관되어 있습니다. 예를들어 Institute of Health and Welfare는 2022년에는 인구의 2%에 해당하는 약 51만 4,000명이 관절 류마티스를 앓고 있다고 보고했습니다. 2022년에는 관련 사망 1,322명, 인구 10만 명당 5.1명의 사망이 기록되어 전체 사망의 0.7%에 해당합니다.

편평태선 시장의 주요 기업들은 표적 약물 전달을 개선하고 전신 부작용을 줄이기 위해 리포솜 제제와 같은 혁신적인 접근법 개발에 주력하고 있습니다. 리포솜 제제는 활성 성분을 지질 이중층으로 구성된 작은 구형 소포인 리포솜에 봉입한 첨단 약물 전달 시스템입니다. 이 제제는 의약품의 안정성을 높이고 흡수를 개선하며, 신체 다른 부위에 대한 노출을 최소화하면서 환부에 정밀하게 전달할 수 있습니다. 예를 들어, 2025년 2월, 중증 질환 치료에 주력하는 미국 생명공학 기업인 Lipella Pharmaceuticals Inc.는 LP 310에 대한 확대 접근 프로그램에 대해 미국 식품의약국(FDA)의 승인을 받았습니다. 이 제품은 구강 편평태선 환자에게 표적화된 완화를 제공하면서 전신 노출을 제한하기 위해 개발된 타크로리무스의 리포좀 제형입니다. 이 프로그램은 심각한 또는 생명을 위협하는 질환을 앓고 있으며 대체 치료 옵션이 없는 환자들이 임상 시험 전에도 규제 승인을 기다리지 않고 치료에 접근할 수 있도록 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 편평태선의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 편평태선 시장 : 성장률 분석
• 세계의 편평태선 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 편평태선 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 편평태선 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 편평태선 시장 : 질환 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 편평태선
• 구강 편평태선
• 성기 편평태선
• 색소성 편평태선
• 세계의 편평태선 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 국소요법
• 전신요법
• 광선요법
• 대체 치료
• 세계의 편평태선 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 국소
• 경구
• 정맥내
• 피내
• 세계의 편평태선 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 홈케어
• 전문 클리닉
• 기타
• 세계의 편평태선 시장 : 편평태선 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 구진편 평태선
• 비후성 편평태선
• 광선성 편평태선
• 선상 편평태선
• 환상 편평태선
• 세계의 편평태선 시장 : 구강 편평태선 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 망상 구강 편평태선
• 구강 비란성 편평태선
• 위축성 구강 편평태선
• 플라크 모양 구강 편평태선
• 수포성 구강 편평태선
• 세계의 편평태선 시장 : 성기 편평태선 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 미란 성기 편평태선
• 구진 성기 편평태선
• 환상 생식기 편평태선
• 외음질 잇몸 증후군
• 세계의 편평태선 시장 : 색소성 편평태선 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 확산성 색소성 편평태선
• 얼룩 색소성 편평태선
• 선형 색소성 편평태선
• 모낭 주위 색소성 편평태선
• 굴곡성 색소성 편평태선

제7장 지역별, 국가별 분석

• 세계의 편평태선 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 편평태선 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 편평태선 시장 : 경쟁 구도
• 편평태선 시장 : 기업 프로파일
  • Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
  • AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Dr. Reddy's Laboratories Ltd
• Amneal Pharmaceuticals Inc.
• Hikma Pharmaceuticals plc
• LEO Pharma A/S
• Basilea Pharmaceutica Ltd.
• UCB SA

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 편평태선 시장(2029년) : 새로운 기회를 제공하는 국가
• 편평태선 시장(2029년) : 새로운 기회를 제공하는 부문
• 편평태선 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

HBR

영문 목차

영문목차

Lichen planus is a persistent inflammatory condition that targets the skin, mucous membranes, and occasionally the nails or hair. It is marked by the appearance of purplish, itchy, flat-topped lesions, typically seen on the wrists, ankles, and lower back. The condition can also impact the inside of the mouth, leading to white, lace-including patches or painful ulcers.

The primary forms of the disease include lichen planus, oral lichen planus, genital lichen planus, and lichen planus pigmentosus. It is a chronic autoimmune disorder in which the immune system erroneously attacks the skin and mucous membranes. Treatment options encompass topical therapies, systemic therapies, phototherapy, and alternative approaches. These therapies are administered through various routes, including topical, oral, intravenous, and intradermal methods, and are used across healthcare settings such as hospitals, homecare, specialty clinics, and other facilities.

The lichen planus market research report is one of a series of new reports from The Business Research Company that provides lichen planus market statistics, including lichen planus industry global market size, regional shares, competitors with a lichen planus market share, detailed lichen planus market segments, market trends and opportunities, and any further data you may need to thrive in the lichen planus industry. The lichen planus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lichen planus market size has grown strongly in recent years. It will grow from $1.18 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be credited to increased awareness of skin-related conditions, enhanced access to medical care, a rising elderly population, the proliferation of dermatology clinics, and higher healthcare expenditures.

The lichen planus market size is expected to see strong growth in the next few years. It will grow to $1.66 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The projected growth in the forecast period can be attributed to increasing demand for biologic therapies, continuous clinical research into new treatment options, the expansion of teledermatology services, a heightened emphasis on personalized medicine, and the development of healthcare infrastructure in emerging regions. Key trends expected during this period include advancements in targeted biologics, the application of artificial intelligence in dermatological diagnostics, innovative drug delivery systems, the adoption of telemedicine platforms, wearable devices for skin monitoring, and the use of 3D skin imaging technologies.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the lichen planus market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy tissues. These conditions include rheumatoid arthritis, lupus, type 1 diabetes, multiple sclerosis, and psoriasis. The rise in autoimmune diseases is influenced by genetic predisposition, where specific gene variations affect immune system function, as well as abnormalities in connective tissues. This growing occurrence of autoimmune disorders reflects a broader issue of immune system dysregulation and is linked to a higher number of lichen planus cases. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that approximately 514,000 people or 2 percent of the population were living with rheumatoid arthritis in 2022. This condition accounted for 2 percent of the total disease burden and 16 percent of the musculoskeletal conditions burden in 2023, with 1,322 related deaths or 5.1 deaths per 100,000 people recorded in 2022, representing 0.7 percent of all deaths. Therefore, the rising prevalence of autoimmune diseases is a major factor fueling the growth of the lichen planus market.

Leading companies in the lichen planus market are focusing on the development of innovative approaches such as liposomal formulations to improve targeted drug delivery and reduce systemic side effects. Liposomal formulations are advanced drug delivery systems in which active ingredients are enclosed within liposomes, which are small spherical vesicles composed of lipid bilayers. These formulations help enhance drug stability, improve absorption, and allow for precise delivery to affected areas while minimizing exposure to the rest of the body. For example, in February 2025, Lipella Pharmaceuticals Inc., a biotechnology company based in the United States that focuses on treatments for serious diseases, received approval from the United States Food and Drug Administration for an expanded access program for LP 310. This product is a liposomal formulation of tacrolimus, created to deliver targeted relief to patients with oral lichen planus while limiting systemic exposure. The program enables patients with serious or life threatening conditions who lack alternative treatment options to access therapies outside of clinical trials prior to full regulatory approval.

In September 2024, Eli Lilly and Company, a U.S.-based pharmaceutical company, formed a partnership with EVA Pharma to improve access to baricitinib (Olumiant) in 49 low- to middle-income countries across Africa. This collaboration aims to reach approximately 20,000 patients by 2030, targeting conditions such as lichen planus, rheumatoid arthritis, alopecia areata, and atopic dermatitis. Under the agreement, Lilly will provide manufacturing expertise to help EVA Pharma locally produce and distribute the medication. EVA Pharma is an Egypt-based pharmaceutical company, specializing in the production and distribution of generic prescription medications across a wide range of therapeutic areas.

Major players in the lichen planus market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc, AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals plc, LEO Pharma A/S, Basilea Pharmaceutica Ltd., UCB S.A., Almirall SA, and Lipella Pharmaceuticals Inc.

North America was the largest region in the lichen planus market in 2024. The regions covered in lichen planus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lichen planus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lichen planus market consists of revenues earned by entities by providing services such as narrowband UVB therapy, oral hygiene counseling, and dental check-ups. The market value includes the value of related goods sold by the service provider or included within the service offering. The lichen planus market also includes sales of topical corticosteroids, systemic immunosuppressants, antihistamines, biologic therapies, phototherapy equipment, diagnostic tools, and herbal and alternative remedies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lichen Planus Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lichen planus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lichen planus ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lichen planus market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Lichen Planus; Oral Lichen Planus; Genital Lichen Planus; Lichen Planus Pigmentosus
• 2) By Treatment Type: Topical Therapies; Systemic Therapies; Phototherapy; Alternative Treatment
• 3) By Route Of Administration: Topical; Oral; Intravenous; Intradermal
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Lichen Planus: Papular Lichen Planus; Hypertrophic Lichen Planus; Actinic Lichen Planus; Linear Lichen Planus; Annular Lichen Planus
• 2) By Oral Lichen Planus: Reticular Oral Lichen Planus; Erosive Oral Lichen Planus; Atrophic Oral Lichen Planus; Plaque-Like Oral Lichen Planus; Bullous Oral Lichen Planus
• 3) By Genital Lichen Planus: Erosive Genital Lichen Planus; Papular Genital Lichen Planus; Annular Genital Lichen Planus; Vulvovaginal-Gingival Syndrome
• 4) By Lichen Planus Pigmentosus: Diffuse Lichen Planus Pigmentosus; Blotchy Lichen Planus Pigmentosus; Linear Lichen Planus Pigmentosus; Perifollicular Lichen Planus Pigmentosus; Flexural Lichen Planus Pigmentosus
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lichen Planus Market Characteristics

3. Lichen Planus Market Trends And Strategies

4. Lichen Planus Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lichen Planus Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lichen Planus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lichen Planus Market Growth Rate Analysis
• 5.4. Global Lichen Planus Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lichen Planus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lichen Planus Total Addressable Market (TAM)

6. Lichen Planus Market Segmentation

• 6.1. Global Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lichen Planus
• Oral Lichen Planus
• Genital Lichen Planus
• Lichen Planus Pigmentosus
• 6.2. Global Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Therapies
• Systemic Therapies
• Phototherapy
• Alternative Treatment
• 6.3. Global Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Oral
• Intravenous
• Intradermal
• 6.4. Global Lichen Planus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.5. Global Lichen Planus Market, Sub-Segmentation Of Lichen Planus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Papular Lichen Planus
• Hypertrophic Lichen Planus
• Actinic Lichen Planus
• Linear Lichen Planus
• Annular Lichen Planus
• 6.6. Global Lichen Planus Market, Sub-Segmentation Of Oral Lichen Planus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reticular Oral Lichen Planus
• Erosive Oral Lichen Planus
• Atrophic Oral Lichen Planus
• Plaque-Like Oral Lichen Planus
• Bullous Oral Lichen Planus
• 6.7. Global Lichen Planus Market, Sub-Segmentation Of Genital Lichen Planus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Erosive Genital Lichen Planus
• Papular Genital Lichen Planus
• Annular Genital Lichen Planus
• Vulvovaginal-Gingival Syndrome
• 6.8. Global Lichen Planus Market, Sub-Segmentation Of Lichen Planus Pigmentosus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diffuse Lichen Planus Pigmentosus
• Blotchy Lichen Planus Pigmentosus
• Linear Lichen Planus Pigmentosus
• Perifollicular Lichen Planus Pigmentosus
• Flexural Lichen Planus Pigmentosus

7. Lichen Planus Market Regional And Country Analysis

• 7.1. Global Lichen Planus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lichen Planus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lichen Planus Market

• 8.1. Asia-Pacific Lichen Planus Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lichen Planus Market

• 9.1. China Lichen Planus Market Overview
• 9.2. China Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lichen Planus Market

• 10.1. India Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lichen Planus Market

• 11.1. Japan Lichen Planus Market Overview
• 11.2. Japan Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lichen Planus Market

• 12.1. Australia Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lichen Planus Market

• 13.1. Indonesia Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lichen Planus Market

• 14.1. South Korea Lichen Planus Market Overview
• 14.2. South Korea Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lichen Planus Market

• 15.1. Western Europe Lichen Planus Market Overview
• 15.2. Western Europe Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lichen Planus Market

• 16.1. UK Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lichen Planus Market

• 17.1. Germany Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lichen Planus Market

• 18.1. France Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lichen Planus Market

• 19.1. Italy Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lichen Planus Market

• 20.1. Spain Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lichen Planus Market

• 21.1. Eastern Europe Lichen Planus Market Overview
• 21.2. Eastern Europe Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lichen Planus Market

• 22.1. Russia Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lichen Planus Market

• 23.1. North America Lichen Planus Market Overview
• 23.2. North America Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lichen Planus Market

• 24.1. USA Lichen Planus Market Overview
• 24.2. USA Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lichen Planus Market

• 25.1. Canada Lichen Planus Market Overview
• 25.2. Canada Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lichen Planus Market

• 26.1. South America Lichen Planus Market Overview
• 26.2. South America Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lichen Planus Market

• 27.1. Brazil Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lichen Planus Market

• 28.1. Middle East Lichen Planus Market Overview
• 28.2. Middle East Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lichen Planus Market

• 29.1. Africa Lichen Planus Market Overview
• 29.2. Africa Lichen Planus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lichen Planus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lichen Planus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lichen Planus Market Competitive Landscape And Company Profiles

• 30.1. Lichen Planus Market Competitive Landscape
• 30.2. Lichen Planus Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Lichen Planus Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Novartis AG
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company
• 31.7. Eli Lilly and Company
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Dr. Reddy's Laboratories Ltd
• 31.11. Amneal Pharmaceuticals Inc.
• 31.12. Hikma Pharmaceuticals plc
• 31.13. LEO Pharma A/S
• 31.14. Basilea Pharmaceutica Ltd.
• 31.15. UCB S.A.

32. Global Lichen Planus Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lichen Planus Market

34. Recent Developments In The Lichen Planus Market

35. Lichen Planus Market High Potential Countries, Segments and Strategies

• 35.1 Lichen Planus Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lichen Planus Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lichen Planus Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료